|
Volumn 4, Issue 6, 1997, Pages 267-273
|
Immunotherapy for recurrent pregnancy loss: 'Standard of care or buyer beware'
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CARDIOLIPIN;
CORTICOSTEROID;
HEPARIN;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOGLOBULIN M ANTIBODY;
LEUKOCYTE ANTIBODY;
LUPUS ANTICOAGULANT;
PHOSPHATIDYLSERINE;
PHOSPHOLIPID ANTIBODY;
PROGESTERONE;
ALLOIMMUNITY;
ANAPHYLAXIS;
ANTICOAGULANT THERAPY;
ANTIPHOSPHOLIPID SYNDROME;
AUTOIMMUNITY;
CLINICAL TRIAL;
DRUG COST;
EDITORIAL;
FETUS WASTAGE;
HEADACHE;
HUMAN;
HYPOTENSION;
IMMUNIZATION;
IMMUNOTHERAPY;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVAGINAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
NAUSEA;
PRIORITY JOURNAL;
RECURRENT ABORTION;
SUBCUTANEOUS DRUG ADMINISTRATION;
SUPPOSITORY;
THROMBOSIS PREVENTION;
ABORTION, HABITUAL;
ADRENAL CORTEX HORMONES;
ANTICOAGULANTS;
ANTIPHOSPHOLIPID SYNDROME;
ASPIRIN;
FEMALE;
HEPARIN;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
IMMUNOTHERAPY;
LEUKOCYTES;
PREGNANCY;
PROGESTERONE;
THROMBOSIS;
|
EID: 0030698275
PISSN: 10715576
EISSN: None
Source Type: Journal
DOI: 10.1016/S1071-5576(97)00069-5 Document Type: Editorial |
Times cited : (17)
|
References (115)
|